Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.

Eli M. Roth,James M. McKenney,Maureen T. Kelly,Carolyn M. Setze,Dawn M. Carlson,Alex Gold,James C. Stolzenbach,Laura A. Williams,Peter H. Jones

Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.

2010

Eli M. Roth
James M. McKenney
Maureen T. Kelly
Carolyn M. Setze
Dawn M. Carlson
Alex Gold
James C. Stolzenbach
Laura A. Williams
Peter H. Jones

Objectives To evaluate the efficacy and safety of fixed-dose combinations of rosuvastatin and fenofibric acid (rosuvastatin/fenofibric acid) compared with simvastatin in patients with high levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG).

Keywords:

Fenofibrate
Hypertriglyceridemia
Cardiology
Cholesterol
Rosuvastatin
Simvastatin
Internal medicine
Statin
Combination therapy
Diabetes mellitus
Pharmacology
Medicine
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations